Why the study?
Does Gallic acid prevent doxorubicin-induced testicular and epididymal toxicity in an experimental rat model?
Does Gallic acid prevent doxorubicin-induced testicular and epididymal toxicity in an experimental rat model?
Gallic acid shows protective effects against doxorubicin-induced testicular and epididymal toxicity in a rat model by reducing oxidative stress and apoptosis.
GA attenuates DOX-induced oxidative stress and sperm abnormalities in rats; leaves open any role in human fertility preservation.
The effect of Gallic acid (GA) on doxorubicin (DOX)-induced testicular and epididymal toxicity was investigated in experimental rat model. The rats were randomly divided into six groups of 10 animals per group. Rats in group A received clean tap water ad libitum. Rats in group B were administered DOX intraperitoneally at 15 mg/kg on the eighth day of the experiment. Animals in groups C and D received 60 and 120 mg/kg GA orally for 7 days with 15 mg/kg DOX on the eighth day. Rats in groups E and F received 60 and 120 mg/kg GA alone orally for 7 days. The animals were sacrificed 24 hr after the last administration. DOX administration led to a significant (p < 0.05) increase in hydrogen peroxide and malondialdehyde levels with significant reduction in antioxidant enzymes and reduced glutathione levels. DOX administration also led to a significant increase in total sperm abnormalities and prolactin together with a significant decrease in testosterone levels. Immunohistochemistry revealed higher expressions of caspase 3 in the testicular tissues of rats that received DOX alone. Together, pre-treatment with GA attenuated markers of oxidative stress, reversed sperm abnormality and ameliorated the observed aberration in plasma testosterone and prolactin levels.
No takes yet. Share an insight, caveat, or question.
Olusoji et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: